CN1114425C - Chinese patent medicine for treating coronary heart disease and hypertension - Google Patents
Chinese patent medicine for treating coronary heart disease and hypertension Download PDFInfo
- Publication number
- CN1114425C CN1114425C CN00112933A CN00112933A CN1114425C CN 1114425 C CN1114425 C CN 1114425C CN 00112933 A CN00112933 A CN 00112933A CN 00112933 A CN00112933 A CN 00112933A CN 1114425 C CN1114425 C CN 1114425C
- Authority
- CN
- China
- Prior art keywords
- chinese patent
- parts
- heart disease
- coronary heart
- patent medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides a Chinese patent medicine for mainly treating coronary diseases and hypertension, which comprises four raw materials of traditional Chinese medicines of oyster shell, glossy privet fruit, rhizoma chuanxiong and rehmannia root, all of which are processed into capsules, tablets or aqueous agents according to a certain proportion of parts by weight. The prescription of the medicine can activate yang, remove dampness by diuresis, activate blood circulation, dissipate blood stasis, tonify the kidney and nourish yin, and in addition, the present invention has a preferable therapeutic effect on aging diseases such as diabetes, gout, hyperostosis, cataracts, etc.
Description
The present invention relates to a kind of is that raw material is mainly treated coronary heart disease and hypertensive Chinese patent medicine with the Chinese crude drug, and other senile diseases such as diabetes, gout, hyperosteogeny, cataract are also had curative effect preferably.
Since the reform and opening-up, because the generally raising of market economy competition and living standards of the people causes the sickness rate of coronary heart disease, hypertension, diabetes, gout, hyperosteogeny and cataract or the like senile disease to increase year by year.This class disease, if use western medicine for a long time, the side effect of clinical practice proof Western medicine is bigger, effect is undesirable, the reason of searching to the bottom is that these senile diseases usually are to occur together mutually and give birth to, and the doctor trained in Western medicine theory is the method for partial analysis, is difficult to overcome the disease of this allomeric function sexual maladjustment of senile disease.For this reason, people are earnestly seeking to treat senile disease based on the theory of Chinese medical science of globality system thinking and method, a kind of compound method ＂ (publication number is CN1066602A) of ＂ hypoglycemic compound capsule is disclosed on " Chinese patent communique ", though this prescription cures mainly the diabetes of interior-heat caused by deficiency of YIN certain curative effect is arranged, but weak point is: (1) this side only limits to treat diabetes, but in fact, diabetes are individualism seldom, often being attended by also (continues) sends out disease coronary heart disease, hypertension etc., not good enough to this curative effect; (2) diabetes are chronic disease, the kidney usually involved in chronic disease, and qi depression to blood stasis, this side's medicine does not have strong promoting flow of QI and blood medicine, and it is undesirable to control chronic diabetes; (3) this side contains Radix Ginseng Rubra, the Radix Astragali, to diseases caused by exogenous pathogenic factor ailment said due to cold or exposure person, can rise and draw the trouble that heresy is entered the room; (4) this prescription cost is higher, has 9 medicines to decoct 1-2 hour again, only uses medicine juice, waste bigger, the processor difficulty.A kind of ＂ hypotensive palsy-treating preparation and preparation method thereof ＂ (publication number is CN1092666A) is also disclosed on " Chinese patent communique ", though it is effective in cure that heart disease, cerebral thrombosis that this invention causes to dizzy anemia, hypertension, by hypertension cause hemiplegia, sciatic nerve, but weak point is: (1) this side should not be used for the treatment of the coronary heart disease and the hypertension of metabolic diseases such as the diabetes that occur together, gout with wine, white sugar preparation; (2) this side is a medicated wine, should not use the gastrointestinal disease patient; (3) this side is a medicated wine, takes for a long time, influences the liver metabolism function; (4) price is expensive.In sum, existing Chinese patent medicine, the one, curative effect is not good enough, and the 2nd, lay particular emphasis on single therapy, can not play the effect of Comprehensive Treatment.
Purpose of the present invention is intended to overcome above-mentioned the deficiencies in the prior art, the inventor is through studying intensively theory of Chinese medical science with great concentration and by a large amount of clinical practices decades, propose that a kind of cost is low, the simple main treatment coronary heart disease of processor and hypertensive Chinese patent medicine, and concurrency diseases such as gout, diabetes and hyperosteogeny are had better curative effect.
Above-mentioned Chinese patent medicine has another name called controls the spirit of flat coronary disease blood.
The technical scheme that realizes above-mentioned purpose be a kind of be raw material with the Chinese crude drug, the main treatment coronary heart disease and the hypertensive Chinese patent medicine that after scientific ingredients processing, make, agent shape is capsule, tablet or water preparation, the raw material of this Chinese patent medicine is made up of Concha Ostreae, Fructus Ligustri Lucidi, Rhizoma Chuanxiong and the Radix Rehmanniae four flavor raw material of Chinese medicine it, and its raw material umber by weight ratio is 3～6 parts of Concha Ostreaes, 2～4 parts of Fructus Ligustri Lucidis, 2～5 parts of Rhizoma Chuanxiongs, 3～6 parts in the Radix Rehmanniae.
The batching of above-mentioned Chinese patent medicine umber by weight ratio is 4 parts in 3 parts of Concha Ostreaes, 2 parts of Fructus Ligustri Lucidis, 5 parts of Rhizoma Chuanxiongs and the Radix Rehmanniae.
Also can include vitamin C, compound vitamin B in the batching.
The preparation method of above-mentioned Chinese patent medicine comprises batching, washes, dries, dry, pulverize, sieve, encapsulated getting product, making step is as follows:
A, batching are by the described weight proportion weighing of claim 1, the Radix Rehmanniae cleaned dried, and in 60～70 ℃ of dryings 6～8 hours,
B, batching are by the described weight proportion weighing of claim 1, Fructus Ligustri Lucidi, Rhizoma Chuanxiong and Concha Ostreae cleaned dried, and in 60～70 ℃ of dryings 2～3 hours,
C, will mix through the Chinese medicine of step a, b and pulverize, cross 80～100 mesh sieves,
D, the fine powder of step c is packed in the 0.5g capsule.
Among the above-mentioned steps c, also can and after being mixed together, pulverize in the Chinese medicine of step a, b vitamin C, compound vitamin B.
Because the inventor is engaged in the clinical practice and the theory study of senile diseases such as diabetes, gout, coronary heart disease, hypertension, hyperosteogeny and cataract for a long time, the reason that these overall function disorders are produced has comparatively rich experience.Utilize Concha Ostreae to be rich in ferrum, manganese, nickel, copper, strengthen the three major nutrient metabolism, eliminate free radical in the blood; Rhizoma Chuanxiong is rich in zinc, ferrum, copper and is beneficial to blood circulation promoting and blood stasis dispelling, eliminates free radical, has strengthened the metabolic function to fat, protein and sugar; Utilize Fructus Ligustri Lucidi to be rich in molybdenum, ferrum, nickel, zinc, chromium, blood fat reducing, cholesterol reducing, blood sugar lowering, the enhancing body metabolic function utilizes the Radix Rehmanniae to be rich in zinc, chromium, strontium, promotes various physiological metabolism functions in the body, gets rid of refuse, blood fat reducing, blood sugar lowering, falls blood uric acid etc.In addition, also contain necessary other trace element in a large amount of human bodies in these four kinds of Chinese crude drugs, according to consumption proportion of the present invention, show that through a large amount of clinical practices the present invention can activate yang, dampness removing is loaded, and invigorates blood circulation to improve cardiac blood supply deficiency before and after alleviating heart, alleviate myocardial oxygen consumption, improve myocardial blood circulation, heart tonifying, the kidney tonifying YIN nourishing is treatment coronary heart disease and hypertension Chinese patent medicine evident in efficacy with blood sugar lowering, blood fat, cholesterol and blood pressure.In addition, the present invention's energy blood sugar lowering, strengthen the liver function, to promote the metabolism of protein, fat and sugar, diabetes, gout, hyperosteogeny etc. are all had preferably curative effect, and (see Appendix 1～8, these adnexaes are for the original bill application number is 97107839.4, the applying date is the adnexa that 97.12.24, denomination of invention provide in the statement to the examination reports first time for " effectively treating the Chinese patent medicine of senile disease ".)。
The present invention is further detailed explanation below by embodiment:
Embodiment one: a kind of main treatment coronary heart disease and hypertensive Chinese patent medicine, its raw material be Concha Ostreae 1500g, Fructus Ligustri Lucidi 1000g, Rhizoma Chuanxiong 2500g, Radix Rehmanniae 2000g by weight ratio.
The preparation method of this batching Chinese patent medicine comprises batching, washes, dries, dry, pulverize, sieve, encapsulated getting product, making step is as follows:
A, batching are by the described weight proportion weighing of claim 1, the Radix Rehmanniae cleaned dried, and in 60～70 ℃ of dryings 6～8 hours,
B, batching are by the described weight proportion weighing of claim 1, Fructus Ligustri Lucidi, Rhizoma Chuanxiong and Concha Ostreae cleaned dried, and in 60～70 ℃ of dryings 2～3 hours,
C, will mix through the Chinese medicine of step a, b and pulverize, cross 80～100 mesh sieves,
D, the fine powder of step c is packed in the 0.5g capsule.
Also can in above-mentioned steps c, add vitamin C 60g, compound vitamin B 0.1884g and after the Chinese medicine of step a, b is mixed together, pulverize.
The characteristics of present embodiment Chinese patent medicine: blood fat reducing, cholesterol reducing, stronger blood circulation invigorating efficacies strengthens and promotes body fat, carbohydrate metabolism function, fundamentally improves the painstaking effort circulation, effectively treats coronary heart disease and hypertension.
Embodiment two: a kind of main treatment coronary heart disease and hypertensive Chinese patent medicine, its raw material be Concha Ostreae 3000g, Fructus Ligustri Lucidi 1000g, Rhizoma Chuanxiong 1500g, Radix Rehmanniae 1500g by weight ratio.
The preparation method of this batching Chinese patent medicine is with embodiment one.
The characteristics of present embodiment Chinese patent medicine: suppressing the hyperactive liver, YANG hyperactivity suppressing, kidney tonifying are invigorated blood circulation, and have free radical effect in blood pressure lowering, blood fat reducing, cholesterol reducing, the elimination blood, are particularly useful for hypertension secondary coronary heart disease, and the treatment hyperosteogeny is also had better curative effect.
Embodiment three: a kind of main treatment coronary heart disease and hypertensive Chinese patent medicine, its raw material be Concha Ostreae 1500g, Fructus Ligustri Lucidi 2000g, Rhizoma Chuanxiong 1000g, Radix Rehmanniae 3000g by weight ratio.
The preparation method of this batching Chinese patent medicine is with embodiment one.
The characteristics of present embodiment Chinese patent medicine: kidney tonifying is invigorated blood circulation, suppressing the hyperactive liver, YANG hyperactivity suppressing, has blood fat reducing, cholesterol reducing, improves painstaking effort circulation effect, is particularly useful for treating coronary heart disease accompanied with hypertension disease, and the treatment diabetes are had better curative effect.
In addition, be principal agent with above-mentioned four flavor Chinese medicines, add some other raw material of Chinese medicine again, therapeutic effect is better.
Embodiment four: a kind of main treatment coronary heart disease and hypertensive Chinese patent medicine, its raw material by weight ratio Concha Ostreae 2000g, Fructus Ligustri Lucidi 2000g, Rhizoma Chuanxiong 2500g, Radix Rehmanniae 2000g, 1500 parts of the Rhizoma Atractylodis Macrocephalaes, Poria 1500g, Polyporus 1000g, Rhizoma Alismatis 1000g, Ramulus Cinnamomi 1000g, Cortex Eucommiae 1000g, Radix Puerariae 1000g, Radix Ophiopogonis 2000g, Rhizoma Anemarrhenae 400g, Fructus Lycii 1000g and Rhizoma Coptidis 100g.
The preparation method of this batching Chinese patent medicine:
1, a Radix Rehmanniae, Radix Ophiopogonis, Fructus Lycii were cleaned and to dry, in 60～70 ℃ of dryings 6～8 hours.
The b Rhizoma Atractylodis Macrocephalae, Poria, Polyporus, Rhizoma Alismatis, Ramulus Cinnamomi, Fructus Ligustri Lucidi, Rhizoma Chuanxiong, Radix Puerariae, the Rhizoma Anemarrhenae, the Cortex Eucommiae, Rhizoma Coptidis, Concha Ostreae were cleaned and are dried, in 60～70 ℃ of dryings 2～3 hours.
2, a in the above-mentioned steps 1 and b are mixed the back pulverizing, cross 80～100 mesh sieves;
3, step 2 gained fine powder is packed in the 0.5g capsule.
The characteristics of present embodiment Chinese patent medicine: activate yang, dampness removing to be to alleviate load before and after the heart, invigorates blood circulation to improve cardiac blood supply deficiency, alleviates myocardial oxygen consumption, improves myocardial blood circulation, heart tonifying.The kidney tonifying YIN nourishing is with blood fat reducing, cholesterol, and this batching is particularly suitable for treating coronary heart disease, and hypertension is also had better curative effect.
Embodiment five: a kind of main treatment coronary heart disease and hypertensive Chinese patent medicine, its prescription for Concha Ostreae 2500g, Fructus Ligustri Lucidi 2000g, Rhizoma Chuanxiong 2000g, Radix Rehmanniae 2000g, Rhizoma Atractylodis Macrocephalae 1500g, Poria 1500g, Polyporus 1000g, Rhizoma Alismatis 500g, Ramulus Cinnamomi 500g, Cortex Eucommiae 2000g,, Radix Puerariae 1500g, Radix Ophiopogonis 1500g, Rhizoma Anemarrhenae 400g, Fructus Lycii 1000g and Rhizoma Coptidis 100g.
The preparation method of Chinese patent medicine is with embodiment four.
Embodiment six: a kind of main treatment coronary heart disease and hypertensive Chinese patent medicine, its raw material be by weight ratio Rhizoma Atractylodis Macrocephalae 2000g, Poria 1500g, Polyporus 1000g, Rhizoma Alismatis 1000g, Ramulus Cinnamomi 1000g, Rhizoma Chuanxiong 2000g, Concha Ostreae 2000g, Cortex Eucommiae 1500g, Fructus Ligustri Lucidi 2000g, Radix Puerariae 1000g, Radix Rehmanniae 2000g, Radix Ophiopogonis 1500g, Rhizoma Anemarrhenae 400g, Fructus Lycii 1000g and Rhizoma Coptidis 100g.
The preparation method of Chinese patent medicine is with embodiment four.
Chinese patent medicine also can be water preparation except that adopting above-mentioned capsule form, it is to be soaked in water about half an hour after a in the above-mentioned steps 1, b are mixed, and through the filtration of removing slag, extracts medicinal liquid half an hour after the heating of reuse temperature fire is boiled, and bottling gets product.
Chinese patent medicine also can be tablet, and its preparation method is a prior art.
In the foregoing description five and six, also can add appropriate vitamin C and compound vitamin B as required, this moment, the preparation method of Chinese patent medicine only needed in step 2 vitamin C and compound vitamin B are mixed pulverizing afterwards with a, b in the step 1, crossing 80～100 mesh sieves gets final product, other preparation methoies are identical, get vitamin C 60g here, compound vitamin B 9.42g is advisable.
When taking this Chinese medicine capsule, day clothes three times are looked 4～8 of its state of an illness weight clothes at every turn.
In sum, clinical therapeutic efficacy of the present invention is good, and needed raw material is easy to get, and cost is low, and processing technology is simple, and the condition of practicing midwifery is not high, is well suited for the pharmaceutical factory with the encapsulated production line of automatization and practices midwifery.
Claims (5)
1, a kind of main treatment coronary heart disease and hypertensive Chinese patent medicine, it is characterized in that: it is made up of Concha Ostreae, Fructus Ligustri Lucidi, Rhizoma Chuanxiong and the Radix Rehmanniae four flavor raw material of Chinese medicine, and its raw material umber by weight ratio is 3～6 parts of Concha Ostreaes, 2～4 parts of Fructus Ligustri Lucidis, 2～5 parts of Rhizoma Chuanxiongs, 3～6 parts in the Radix Rehmanniae.
2, according to described a kind of main treatment coronary heart disease of claim 1 and hypertensive Chinese patent medicine, it is characterized in that: raw material umber by weight ratio is 4 parts in 3 parts of Concha Ostreaes, 2 parts of Fructus Ligustri Lucidis, 5 parts of Rhizoma Chuanxiongs and the Radix Rehmanniae.
3, according to claim 1 or 2 described a kind of main treatment coronary heart disease and hypertensive Chinese patent medicines, it is characterized in that: also include vitamin C, compound vitamin B in the batching.
4, a kind of is raw material with the Chinese crude drug, process from strand and make a kind of main treatment coronary heart disease and hypertensive Chinese patent medicine, it is characterized in that: preparation method comprises batching, washes, dries, dry, pulverize, sieve, encapsulated getting product, making step is as follows:
A, batching are by the described weight proportion weighing of claim 1, the Radix Rehmanniae cleaned dried, and in 60～70 ℃ of dryings 6～8 hours,
B, batching are by the described weight proportion weighing of claim 1, Fructus Ligustri Lucidi, Rhizoma Chuanxiong and Concha Ostreae cleaned dried, and in 60～70 ℃ of dryings 2～3 hours,
C, will mix through the Chinese medicine of step a, b and pulverize, cross 80～100 mesh sieves,
D, the fine powder of step c is packed in the 0.5g capsule.
5, according to described a kind of main treatment coronary heart disease of claim 5 and hypertensive Chinese patent medicine, it is characterized in that: in step c, vitamin C, compound vitamin B and pulverizing after the Chinese medicine of step a, b is mixed together.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00112933A CN1114425C (en) | 2000-05-15 | 2000-05-15 | Chinese patent medicine for treating coronary heart disease and hypertension |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00112933A CN1114425C (en) | 2000-05-15 | 2000-05-15 | Chinese patent medicine for treating coronary heart disease and hypertension |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97107839A Division CN1060074C (en) | 1997-12-24 | 1997-12-24 | Chinese patent drug for treating effevctively old and feeble type disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1308946A CN1308946A (en) | 2001-08-22 |
| CN1114425C true CN1114425C (en) | 2003-07-16 |
Family
ID=4582755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN00112933A Expired - Fee Related CN1114425C (en) | 2000-05-15 | 2000-05-15 | Chinese patent medicine for treating coronary heart disease and hypertension |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1114425C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1326558C (en) * | 2005-11-10 | 2007-07-18 | 钟厚禄 | Chinese herbal medicine oral liquid for treating high blood pressure and its preparation method |
| CN104027748A (en) * | 2014-06-28 | 2014-09-10 | 李文职 | Traditional Chinese medicinal preparation for treating coronary heart disease |
| CN111840471A (en) * | 2020-08-03 | 2020-10-30 | 候庆荣 | Medicine and food homologous hypertension traditional Chinese medicine composition |
-
2000
- 2000-05-15 CN CN00112933A patent/CN1114425C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1308946A (en) | 2001-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100368006C (en) | Medicine for treating cardiovascular disease | |
| CN1047946C (en) | Preparation for treating senile diseases | |
| CN100435831C (en) | Preparation for treating high blood pressure, high blood fat, obesity, and climacteric syndrome, and preparation method | |
| CN103372135B (en) | Chinese medicinal composition treating cardiovascular and cerebrovascular diseases caused by heart-kidney imbalance | |
| CN101053621A (en) | Traditional Chinese medicinal composition for treating obesity and its preparation method | |
| CN101850057B (en) | Vital nourishing ant wine and preparation method thereof | |
| CN1943769A (en) | An external pharmaceutical for treatment of arrhythmia, coronary heart disease and angina pectoris | |
| CN101032599A (en) | Healthy solution for conditioning skin and losing weight | |
| CN1114425C (en) | Chinese patent medicine for treating coronary heart disease and hypertension | |
| CN101036721A (en) | Deer fetus capsule and its production process | |
| CN101024042A (en) | Medicine preparation for treating rheumatism disease by jointing Chinese medicine and western medicine | |
| CN1175884C (en) | Kidney-reinforcing Yang-invigorating pill for treating sexual impotence, and preparing process thereof | |
| CN1709476A (en) | Mine-tranquilizing soporific capsule | |
| CN1060074C (en) | Chinese patent drug for treating effevctively old and feeble type disease | |
| CN1270758C (en) | Chinese medicinal preparation for treating cerebral apoplexy | |
| CN106038743A (en) | Blood pressure reducing electuary, and preparation method and application thereof | |
| CN1150012C (en) | Chinese patent medicine for treating hyperosteogeny | |
| CN105055851A (en) | Chinese medicinal composition for treatment of diabetes, preparation and application thereof | |
| CN1836718A (en) | Health traditional Chinese medicine for invigorating constitution, strengthening brain and activating blood | |
| CN108079275A (en) | A kind of health Chinese medicine composition for treating hypertension and preparation method thereof | |
| CN101961459B (en) | Oral medicament for treating hemiplegia | |
| CN1168483C (en) | Heart disease treating medicine | |
| CN1836705A (en) | Medicine for treating amblyopia and its preparing method | |
| CN1076622C (en) | Chinese medicine for curing nephritis | |
| CN1247237C (en) | Medicinal composition for treating coronary disease and its preparation and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: LUO JINXIU Free format text: FORMER OWNER: CHEN WEI Effective date: 20060728 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20060728 Address after: 618000 Deyang Institute of sexology, No. 219 Tianshan Road, Sichuan, Deyang Patentee after: Luo Jinxiu Address before: 618000 Huashan North Road East electric hospital, Deyang, Sichuan Patentee before: Chen Wei |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20030716 Termination date: 20100125 |